Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of hepatitis C virus (HCV) protease inhibitors. Its structure enables selective binding and inhibition of viral enzymes, making it valuable in medicinal chemistry for designing potent drug candidates. The compound's chiral centers and functional groups allow for further chemical modifications, enhancing pharmacokinetic properties such as bioavailability and metabolic stability in final drug formulations.